BE

ASGE Journal ScanÖsophagus

Using AI To Identify Patients With Barrett’s Esophagus and Dysplasia From Pathology Reports

Using AI To Identify Patients With Barrett’s Esophagus and Dysplasia From Pathology Reports

Natural language processing (NLP) is a computer technology that uses language cues and context to interpret findings and mine large databases to identify desired clinical

ASGE Journal ScanÖsophagus

Majority of At-Risk Patients Not Screened for Barrett’s Esophagus

Majority of At-Risk Patients Not Screened for Barrett’s Esophagus

The current screening model for Barrett’s esophagus (BE) has limitations because patients need to be identified by their primary care physician and then referred to

ASGE Journal ScanÖsophagus

Optimum Barrett’s Inspection Time Is Critical for a High-Quality Endoscopy

Optimum Barrett’s Inspection Time Is Critical for a High-Quality Endoscopy

Endoscopic surveillance of Barrett’s esophagus (BE) is recommended to reduce mortality and morbidity related to esophageal adenocarcinoma. A thorough endoscopic inspection of a BE segment

ASGE Journal ScanÖsophagus

Artificial Intelligence Continues To Be Impressive for Characterization of Barrett’s Neoplasia

Artificial Intelligence Continues To Be Impressive for Characterization of Barrett’s Neoplasia

Barrett’s esophagus (BE)-related neoplasia is frequently missed during upper endoscopy, and characterization of mucosal changes may help in its detection. The primary aim of this

ASGE Journal ScanÖsophagus

Artificial Intelligence Beats General Endoscopists for the Detection of Barrett’s Neoplasia

Artificial Intelligence Beats General Endoscopists for the Detection of Barrett’s Neoplasia

Barrett’s esophagus (BE) is a precancerous condition that can lead to the development of dysplasia and esophageal adenocarcinoma (neoplasia). Since neoplasia can present as subtle

ASGE Journal ScanÖsophagus

Genetic Risk Loci, Biomarkers, and Lifestyle Risk Factors in Barrett’s Esophagus and Cancer

Genetic Risk Loci, Biomarkers, and Lifestyle Risk Factors in Barrett’s Esophagus and Cancer

Genome-wide association studies (GWAS) involve scanning the DNA of a large cohort to identify any genetic variants associated with the disease in question. Previous GWAS

ASGE Journal ScanÖsophagus

Artificial Intelligence Can Help Extract Dysplasia Diagnoses From Electronic Health Records

Artificial Intelligence Can Help Extract Dysplasia Diagnoses From Electronic Health Records

Natural language processing (NLP) is a branch of artificial intelligence (AI) systems that involves teaching computers the ability to understand written text like how humans

ASGE Journal ScanÖsophagus

Healing of Mucosal Ablation Areas After Radiofrequency Ablation in Patients With Barrett’s Esophagus

Healing of Mucosal Ablation Areas After Radiofrequency Ablation in Patients With Barrett’s Esophagus

Endoscopic therapy for patients with neoplastic Barrett’s esophagus (BE) involves resection followed by mucosal ablation. Radiofrequency ablation (RFA) of the flat BE mucosa leads to

ASGE Journal ScanÖsophagus

Endoscopic Submucosal Dissection Plus Radiofrequency Ablation Exhibits High Eradication Rates in Patients With Barrett’s Esophagus

Endoscopic Submucosal Dissection Plus Radiofrequency Ablation Exhibits High Eradication Rates in Patients With Barrett’s Esophagus

Current strategies for the endoscopic treatment of Barrett’s esophagus (BE) focus on resection of nodular lesions within BE and then the ablation of the flat

ASGE Journal ScanÖsophagus

Artificial Intelligence Detects Dysplasia in Histopathology Slides From Patients With Barrett’s Esophagus

Artificial Intelligence Detects Dysplasia in Histopathology Slides From Patients With Barrett’s Esophagus

The degree of dysplasia in patients with Barrett’s esophagus (BE) is key to determining the application of BE endoscopic therapy and assigning surveillance intervals. Multiple

ASGE Journal ScanÖsophagus

Poor Squamous Regeneration After Barrett’s Endoscopic Therapy Increases Risk for Treatment Failure and Disease Progression

Poor Squamous Regeneration After Barrett’s Endoscopic Therapy Increases Risk for Treatment Failure and Disease Progression

A small subset of patients who undergo Barrett’s endoscopic therapy (BET) using radiofrequency ablation (RFA) will have evidence of poor mucosal healing (mucosal edema, ulcers,

ASGE Journal ScanÖsophagus

Progression in Barrett’s Esophagus Score Can Be Used for Estimating Neoplastic Progression

Progression in Barrett’s Esophagus Score Can Be Used for Estimating Neoplastic Progression

Barrett’s esophagus (BE) is a known precancerous lesion for esophageal dysplasia and adenocarcinoma (EAC); however, it is unclear who will progress to high-grade dysplasia (HGD)

ASGE Journal ScanÖsophagus

Endoscopic Submucosal Dissection Use Changes Histologic Diagnosis in More Than Half of All Patients With Visible Barrett’s Esophagus Neoplasia

Endoscopic Submucosal Dissection Use Changes Histologic Diagnosis in More Than Half of All Patients With Visible Barrett’s Esophagus Neoplasia

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have emerged as important treatment techniques for patients with visible lesions in Barrett’s esophagus (BE). Whereas

Ösophagus

Barrett’s Endoscopic Therapy Using Hybrid-Argon Plasma Coagulation Is Safe and Effective

Barrett’s Endoscopic Therapy Using Hybrid-Argon Plasma Coagulation Is Safe and Effective

Endoscopic therapy for Barrett’s esophagus (BE) usually involves resection of visible lesions by endoscopic mucosal resection followed by mucosal ablation using radio frequency ablation. Hybrid

ASGE Journal ScanÖsophagus

Cryoballoon Ablation Has Similar Efficacy to but Higher Stricture Rates Than Radiofrequency Ablation in Barrett’s Endoscopic Therapy

Cryoballoon Ablation Has Similar Efficacy to but Higher Stricture Rates Than Radiofrequency Ablation in Barrett’s Endoscopic Therapy

Radiofrequency ablation (RFA) is widely utilized in the treatment of neoplastic Barrett’s esophagus (BE) after endoscopic resection of all visible lesions. Cryotherapy is another form

ASGE Journal ScanÖsophagus

Barrett’s Esophagus-Specific Training Improves Adherence to Diagnosis and Treatment Guidelines

Barrett’s Esophagus-Specific Training Improves Adherence to Diagnosis and Treatment Guidelines

The accurate diagnosis and management of patients with Barrett’s esophagus (BE) are important for the early recognition and minimally invasive treatment of BE neoplasia. Despite

ASGE Journal ScanÖsophagus

Upper GI Screening Endoscopy in Individuals With a Family History of Barrett’s Esophagus or Esophageal Cancer

Upper GI Screening Endoscopy in Individuals With a Family History of Barrett’s Esophagus or Esophageal Cancer

The incidence of esophageal adenocarcinoma (EAC) continues to increase and is still associated with a poor prognosis with a 5-year survival rate of 20%. The

ASGE Journal ScanÖsophagus

Artificial Intelligence During Barrett’s Endoscopy Is Accurate for Reporting Prague Criteria

Artificial Intelligence During Barrett’s Endoscopy Is Accurate for Reporting Prague Criteria

During endoscopy, the extent of Barrett’s esophagus (BE) is quantified by endoscopists using the widely accepted Prague C&M (circumferential and maximal lengths) criteria. Prague C&M

ASGE Journal ScanÖsophagus

Only 80% Eradication Rates of Barrett’s Esophagus With Long-Term Follow-Up of Endoscopic Therapy Studies

Only 80% Eradication Rates of Barrett’s Esophagus With Long-Term Follow-Up of Endoscopic Therapy Studies

Patients with high-grade dysplasia and/or early cancer in Barrett’s esophagus (BE) are treated with endoscopic therapy (BET), with the goal of complete eradication of all

ASGE Journal ScanÖsophagus

Endoscopic Features for Recognizing Buried Barrett’s Esophagus

Endoscopic Features for Recognizing Buried Barrett’s Esophagus

Buried Barrett’s esophagus (BE) mucosa, or subsquamous intestinal metaplasia, is defined as intestinal metaplasia that is present under a lining of endoscopically intact squamous epithelium.

ASGE Journal ScanÖsophagus

Achalasia Patients at Increased Risk for Esophageal Cancer

Achalasia Patients at Increased Risk for Esophageal Cancer

Achalasia can cause food retention, leading to bacterial overgrowth, irritation, and chronic inflammation, a proposed pathophysiological process that may lead to squamous cell carcinoma (SCC).

ASGE Journal ScanÖsophagus

Nonendoscopic Screening for Barrett’s Esophagus: Are We There?

Nonendoscopic Screening for Barrett’s Esophagus: Are We There?

Upper endoscopy (EGD) with biopsy remains the gold standard for the diagnosis of Barrett’s esophagus (BE). Several nonendoscopic techniques (sponge, capsule) have utilized biomarkers, such

ASGE Journal ScanKolon

Radiographic Studies Unreliable for Polyp Detection in Patients With Incomplete Colonoscopy

Radiographic Studies Unreliable for Polyp Detection in Patients With Incomplete Colonoscopy

Douglas K. Rex, MD, FASGE, reviewing Parsa N, et al. Gastrointest Endosc 2020 Feb 4. In a single U.S. center with a large experience performing